Clinical Trial Site

Bern 3010

1 studies enrolling now · 6 studies all time

What they study most

ANCA-Associated Vasculitis, Atypical Hemolytic-Uremic Syndrome, Cerebral Amyloid Angiopathy, Elevated Urinary Oxalate Levels, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 1 (PH1), Recurrent Calcium Oxalate Kidney Stone Disease

Studies at this site

• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 — Completed
• A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels — Stopped early